Page 72 - 2021 Taiwan Food and Drug Administration Annual Report
P. 72
Due to the rapid development of modern ing diagnostic software to ensure the accura-
DQG QHZ PHGLFDO GHYLFHV DQG FRVPHWLFV WKHUH cy of relevant diagnostic results and to help
is an urgent need to establish the analytical promote the development of the country’s
technology for quality management of medical imaging industry to be in line with
YDULRXV SURGXFWV WR H[SDQG WKH WHVWLQJ LWHPV international standard.
LQ FRVPHWLFV DQG WR GHYHORS RU RSWLPL]H
the analytical methods for management of II. Improved cosmetics analytical
GRPHVWLF SURGXFWV ,Q DGGLWLRQ 7)'$ OHDUQ RI techniques
the current status and trends of testing in the
ZRUOG FRPSUHKHQVLYHO\ LPSURYH WKH OHYHO RI ,Q UHFRPPHQGHG WHVW PHWKRGV
analytical techniques and strengthen research IRU FRVPHWLFV ZHUH SXEOLVKHG DQG WKH\ ZHUH
capabilities to be in line with the world’s “Method of Test for Iodopropynyl Butylcar-
standard through international technical bamate in Cosmetics,´ ³Method of Test for
exchange and collaboration. Polysilicone-15 in Cosmetics ´ ³Method of
Test for Polycyclic Aromatic Hydrocarbons
Implementation Strategy in Cosmetics ´ ³Method of Test for Heavy
Metals in Cosmetics,´ ³Method of Test for
I. Established testing and verifi- Restricted Dyes in Cosmetics,´ DQG ³Method
cation methods for innovative of Test for Camphor Benzalkonium Methosul-
intelligent medical devices fate and Benzylidene Camphor Sulfonic Acid
in Cosmetics´ UHFRPPHQGHG WHVW PHWKRGV
,Q VWDQGDUGL]HG WHVW SURFHGXUHV ZHUH including “Method of Test for Hair Dyes in
established to evaluate the minimum perfor- Cosmetics´ DQG ³Microbiological Methods
PDQFH UHTXLUHPHQWV RI HOHFWULF ZKHHOFKDLUV for Cosmetics´ ZHUH UHYLVHG $ WRWDO RI
and a safety test platform for electric wheel- articles including 95 items were published or
chairs was completed to ensure the safety of UHYLVHG GHPRQVWUDWLQJ IUXLWIXO UHVXOWV
users. Methods for the quality verification
of permanent denture laminates have been III. Actively participated in inter-
established to provide the industry as a refer- national events for cosmetics
HQFH IRU SURGXFW YHUL¿FDWLRQ 7KH YHUL¿FDWLRQ
guidelines of the medical imaging diagnostic TFDA is an associated member of the
technology method (draft) and the verifica- European Network of Official Cosmetics
tion guidelines of the artificial intelligence Control Laboratories (OCCLs). We
medical imaging diagnostic software (draft) participated in the 5th and 6th joint session of
have been completed. Follow-up plans will the “European Committee for Cosmetics and
improve the draft and then make it published &RQVXPHU +HDOWK &' 3 &26 DQG 2&&/V´
as a reference for the industry for the devel- via video conference in 2020 to continue
opment and establishment of medical imag- strengthening the collaboration and exchange
70
